Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom line also
Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook
Categories
Health Care
Pfizer (PFE) stock research summary | Q3 2021
Pfizer delivered a solid performance in Q3 2021 with a triple-digit increase in revenue and profits growing many-fold. The company’s COVID-19 vaccine,
AbbVie (ABBV) stock research summary | Q3 2021
The AlphaStreet research report provides actionable data and insights into AbbVie’s fundamentals, the industry, and competition. The report is meant as a
Aurora Cannabis Inc. (ACB) Q1 2022 Earnings Call Transcript
Aurora Cannabis Inc. (NYSE: ACB) Q1 2022 earnings call dated Nov. 09, 2021 Corporate Participants: Ananth Krishnan -- Vice President, Corporate Development & Investor
IPO news: A few points to keep in mind as Vaxxinity makes its market debut this week
The healthcare industry continues to thrive and many companies in this sector have lined up to go public in recent times. One
Cara Therapeutics, Inc. (CARA) Q3 2021 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig -- Senior Analyst Derek Chalmers -- Chief Executive Officer,
Cigna Corporation (CI) Q3 2021 Earnings Call Transcript
Cigna Corporation (NYSE: CI) Q3 2021 earnings call dated Nov. 04, 2021 Corporate Participants: Alexis Jones -- Lead Principal, Investor Relations David Cordani -- President and
Becton, Dickinson and Company (BDX) Q4 2021 Earnings Call Transcript
Becton, Dickinson and Company (NYSE: BDX) Q4 2021 earnings call dated Nov. 04, 2021 Corporate Participants: Nadia Goncalves -- Senior Director, Investor Relations Tom
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Humana Inc. (HUM) Q3 2021 Earnings Call Transcript
Humana Inc. (NYSE: HUM) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Lisa M. Stoner -- Vice President, Investor Relations Bruce D.
Key highlights from Humana Inc. (HUM) Q3 2021 earnings results
Humana Inc. (NYSE: HUM) reported its third quarter financial results for the period ended September 30, 2021. GAAP net income for the
CVS Health Corporation (CVS) Q3 2021 Earnings Call Transcript
CVS Health Corporation (NYSE: CVS) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Susie Lisa -- Senior Vice President of Investor Relations
Infographic: How CVS Health Corporation (CVS) performed in Q3 2021
CVS Health Corporation (NYSE: CVS) reported third quarter 2021 earnings results today. Total revenues increased 10% year-over-year to $73.8 billion. Net income
Pfizer (PFE): Comirnaty and a strong pipeline provides long-term growth opportunity
Shares of Pfizer Inc. (NYSE: PFE) gained 4% on Tuesday after the company delivered strong results for the third quarter of 2021
Pfizer Inc (PFE) Q3 2021 Earnings Call Transcript
Pfizer Inc (NYSE:PFE) Q3 2021 earnings call dated Nov. 02, 2021. Corporate Participants: Chris Stevo -- Senior Vice President and Chief Investment Relations Officer
Key highlights from Pfizer (PFE) Q3 2021 earnings results
Pfizer Inc. (NYSE: PFE) reported third quarter 2021 earnings results today. Revenues more than doubled year-over-year to $24 billion. Reported net income
McKesson Corporation (MCK) Q2 2022 Earnings Call Transcript
McKesson Corporation (NYSE: MCK) Q2 2022 earnings call dated Nov. 01, 2021 Corporate Participants: Rachel Rodriguez -- Investor Relations Brian S. Tyler -- Chief Executive Officer
Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year
Image: iStock Give us a quick overview of the company. Trxade is a market platform that caters to the independent pharmacies that
Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues
Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its third-quarter 2021 earnings today after the closing bell. The revenue increased by 13%
Merck & Co., Inc. (MRK) Q3 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q3 2021 earnings call dated Oct. 28, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert